Statewide

State Board of Emergency Medical, Fire, and Transportation Services (EMFTS Board)

Current109 dose entries34 drugs1 documentOHeffective 2024-12-1191% machine-parsed of 109

State Board of Emergency Medical, Fire, and Transportation Services (EMFTS Board) (OH) carries 34 drugs across 109 dose entries in its current published protocol, effective 2024-12-11.

Drugs and doses34

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	15 mg/kg	PO	not captured	standing	page 177 · source
Other	adult	15 mg/kg	IV	not captured	standing	page 177 · source
Other	peds	15 mg/kg	PO	not captured	standing	page 177 · source
Other	peds	15 mg/kg	IV	not captured	standing	page 177 · source
Mild to moderate pain	adult	15 mg/kg	PO	not captured	standing	pages 60, 177 · source
Mild to moderate pain	adult	15 mg/kg	IV	not captured	standing	page 177 · source
Mild to moderate pain	peds	15 mg/kg	PO	not captured	standing	pages 60, 177 · source
Mild to moderate pain	peds	15 mg/kg	IV	not captured	standing	page 177 · source

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV	not captured	standing	pages 13, 14, 17, 18, 19, 178 · source
SVT	peds	0.1 mg/kg	IV	not captured	standing	pages 13, 14, 17, 18, 19, 178 · source

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 70, 72, 75, 179 · source
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 70, 72, 75, 179 · source
COPD	adult	2.5 mg	NEB	not captured	standing	pages 70, 72, 179 · source
Respiratory distress	adult	2.5 mg	NEB	not captured	standing	pages 75, 179 · source
Respiratory distress	peds	2.5 mg	NEB	not captured	standing	pages 75, 179 · source

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	300 mg	IV/IO	not captured	standing	pages 14, 15, 28, 31, 180 · source
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	pages 14, 15, 28, 31, 180 · source
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 14, 15, 28, 31, 180 · source
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 14, 15, 28, 31, 180 · source

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	160–325 mg	PO	not captured	standing	pages 36, 38, 39, 181 · source

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Asystole / PEA	adult	1 mg	IV	not captured	standing	page 183 · source
Bradycardia	adult	0.5 mg	IV	not captured	standing	pages 13, 16, 182, 183 · source
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 13, 16, 182, 183 · source
Organophosphate poisoning	adult	2 mg	IV/IM	not captured	standing	page 183 · source

Buprenorphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	8 mg	PO	not captured	standing	page 184 · source
Other	adult	8 mg	PO	not captured	standing	page 184 · source

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2.5 g	not captured	not captured	standing	pages 119, 186 · source
Other	peds	2.5 g	not captured	not captured	standing	pages 119, 186 · source

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	25 g	IV	not captured	standing	page 10 · source
Other	adult	50 mL	IV	not captured	standing	pages 10, 187, 188, 189 · source
Other	peds	1 mL/kg	IV	not captured	standing	pages 10, 187, 188, 189 · source

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IV/IM	not captured	standing	pages 77, 190 · source
Other	adult	5 mg	not captured	not captured	standing	pages 77, 190 · source
Other	peds	0.2–0.3 mg/kg	IV/IM	not captured	standing	pages 77, 190 · source

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	IV/IM	not captured	standing	pages 70, 191 · source
Allergic reaction	peds	1 mg/kg	IV/IM	not captured	standing	pages 70, 191 · source

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5–20 mcg/kg	IV	not captured	standing	pages 37, 192 · source

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 69, 75, 194 · source
Anaphylaxis	adult	0.3 mg	SQ	not captured	standing	page 194 · source
Anaphylaxis	adult	0.5 mg	IV	not captured	standing	pages 75, 194 · source
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 69, 75, 194 · source
Anaphylaxis	peds	0.01 mg/kg	SQ	not captured	standing	page 194 · source
Asthma / bronchospasm	adult	0.3–0.5 mg	SQ	not captured	standing	page 194 · source
Asthma / bronchospasm	peds	0.01 mg/kg	SQ	not captured	standing	page 194 · source
Bradycardia	peds	0.01 mg/kg	IV	not captured	standing	pages 13, 194 · source
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 28, 31, 193, 194 · source
Cardiac arrest	adult	2 mg	ET	not captured	standing	pages 29, 31, 194 · source
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 28, 31, 193, 194 · source

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	1 mcg/kg	IM/IN	not captured	standing	pages 61, 195 · source
Severe pain	adult	1 mcg/kg	IV/IO	not captured	standing	pages 61, 195 · source
Severe pain	peds	1 mcg/kg	IM/IN	not captured	standing	pages 61, 195 · source
Severe pain	peds	1 mcg/kg	IV/IO	not captured	standing	pages 61, 195 · source

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	1 mg/kg	IV	not captured	standing	pages 73, 75, 196 · source

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	1–2 mg	IV/IM	not captured	standing	pages 72, 75, 81, 82 · source
Hypoglycemia	adult	0.5–1 mg	IM	not captured	standing	pages 10, 47, 49, 197 · source
Hypoglycemia	adult	0.5–1 mg	IV/SQ	not captured	standing	pages 10, 47, 49, 197 · source
Hypoglycemia	peds	0.5–1 mg	IM	not captured	standing	pages 10, 47, 49, 197 · source
Hypoglycemia	peds	0.5–1 mg	IV/SQ	not captured	standing	pages 10, 47, 49, 197 · source

Hydromorphone

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	0.015 mg/kg	IV/IO/IM	not captured	standing	pages 61, 198 · source
Severe pain	peds	0.015 mg/kg	IV/IO/IM	not captured	standing	pages 61, 198 · source

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	10 mg/kg	PO	not captured	standing	pages 60, 199 · source
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	pages 60, 199 · source

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 mg/kg	IV	not captured	standing	pages 66, 200 · source
Other	adult	4 mg/kg	IM	not captured	standing	pages 66, 200 · source
Other	peds	1 mg/kg	IV	not captured	standing	pages 66, 200 · source
Other	peds	3 mg/kg	IM	not captured	standing	pages 66, 200 · source
Mild to moderate pain	adult	0.5 mg/kg	IN	not captured	standing	pages 61, 200 · source
Mild to moderate pain	peds	0.5 mg/kg	IN	not captured	standing	pages 61, 200 · source
Severe pain	adult	0.25 mg/kg	IV/IO/IM	not captured	standing	pages 61, 200 · source
Severe pain	peds	0.25 mg/kg	IV/IO/IM	not captured	standing	pages 61, 200 · source

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	pages 61, 201 · source
Mild to moderate pain	adult	30 mg	IM	not captured	standing	pages 60, 61, 201 · source
Mild to moderate pain	peds	0.5 mg/kg	IV	not captured	standing	pages 61, 201 · source
Mild to moderate pain	peds	1 mg/kg	IM	not captured	standing	pages 60, 61, 201 · source

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mg/kg	IV	not captured	standing	page 202 · source
VF / pulseless VT	adult	1–1.5 mg/kg	IV/IO	not captured	standing	page 28 · source
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	page 28 · source

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	125 mg	IV/IM	not captured	standing	page 203 · source

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–5 mg	not captured	not captured	standing	pages 65, 66, 204 · source
Other	adult	2–5 mg	IV	not captured	standing	page 43 · source
Other	peds	0.1 mg/kg	not captured	not captured	standing	pages 65, 66, 204 · source
Procedural sedation	adult	3–5 mg	IV	not captured	standing	pages 13, 16 · source
Procedural sedation	adult	5 mg	IV	not captured	standing	pages 14, 15 · source
Seizure	adult	10 mg	IN	not captured	standing	pages 77, 78, 204 · source
Seizure	adult	2–5 mg	IV	not captured	standing	pages 77, 78, 204 · source
Seizure	peds	0.1 mg/kg	IV	not captured	standing	pages 77, 78, 204 · source
Seizure	peds	0.1 mg/kg	IN	not captured	standing	pages 77, 78, 204 · source

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	0.1 mg/kg	IM	not captured	standing	page 61 · source
Severe pain	adult	5 mg	IV	not captured	standing	pages 37, 38, 39, 75, 89, 205 · source

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4 mg	not captured	not captured	standing	pages 9, 10, 11 · source
Opioid overdose	adult	2 mg	IN	not captured	standing	pages 9, 10, 11 · source
Opioid overdose	adult	2 mg	IV/IO/IM/SQ/NEB	not captured	standing	pages 10, 11 · source
Opioid overdose	adult	2 mg	ET	not captured	standing	page 10 · source

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	pages 71, 73 · source
Other	adult	0.4 mg	SL	not captured	standing	pages 36, 37, 38, 39, 75, 208 · source

Nitrous Oxide

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	50% nitrous oxide and 50% oxygen	NEB	not captured	standing	pages 61, 166, 209 · source

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.02–0.04 mcg/kg	IV	not captured	standing	pages 13, 16 · source
Cardiogenic shock	adult	0.05–0.5 mcg/kg	IV	not captured	standing	pages 37, 81 · source
Other	adult	0.05–0.5 mcg/kg	IV	not captured	standing	page 210 · source

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1 tube	PO	not captured	standing	pages 11, 47, 49, 84 · source
Hypoglycemia	peds	1 tube	PO	not captured	standing	pages 11, 47, 49, 84 · source

Procainamide

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	20–50 mg	IV	not captured	standing	pages 14, 15, 19, 20 · source

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1 mEq/kg	IV/IO	not captured	standing	pages 28, 31, 214 · source
Cardiac arrest	peds	1 mEq/kg	IV/IO	not captured	standing	pages 28, 31, 214 · source
Other	adult	25 mEq	IV	not captured	standing	page 66 · source

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 drop	not captured	not captured	standing	pages 51, 52 · source

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g	IV	not captured	standing	pages 93, 127, 131, 136, 215 · source
Other	peds	15 mg/kg	IV	not captured	standing	pages 93, 127, 131, 136, 215 · source

Vasopressin

Indication	Population	Dose	Route	Repeat	Standing	Source
VF / pulseless VT	adult	40 unit	IV	not captured	standing	page 216 · source

Cite this

State Board of Emergency Medical, Fire, and Transportation Services (EMFTS Board), United States EMS Protocol Census. 109 dose entries, effective 2024-12-11.

https://protoquiz.com/census/agencies/state-board-of-emergency-medical-fire-and-transportation-services-emfts-board/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.